[go: up one dir, main page]

AU2001284274A1 - A thiazolidinedione derivative and its use as antidiabetic - Google Patents

A thiazolidinedione derivative and its use as antidiabetic

Info

Publication number
AU2001284274A1
AU2001284274A1 AU2001284274A AU8427401A AU2001284274A1 AU 2001284274 A1 AU2001284274 A1 AU 2001284274A1 AU 2001284274 A AU2001284274 A AU 2001284274A AU 8427401 A AU8427401 A AU 8427401A AU 2001284274 A1 AU2001284274 A1 AU 2001284274A1
Authority
AU
Australia
Prior art keywords
antidiabetic
compound
thiazolidinedione derivative
thiazolidinedione
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001284274A
Inventor
Andrew Simon Craig
Tim Chien Ting Ho
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU2001284274A1 publication Critical patent/AU2001284274A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A novel pharmaceutical compound 5-[4-[2-methyl-N-(2-pyridyl)amino)ethoxy]thiazolidine-2,4-dione fumarate or a solvate thereof, a process for preparing such a compound, a pharmaceutical composition comprising such a compound and the use of such a compound in medicine.
AU2001284274A 2000-09-07 2001-09-05 A thiazolidinedione derivative and its use as antidiabetic Abandoned AU2001284274A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0021978.2A GB0021978D0 (en) 2000-09-07 2000-09-07 Novel pharmaceutical
GB0021978 2000-09-07
PCT/GB2001/003979 WO2002020517A1 (en) 2000-09-07 2001-09-05 A thiazolidinedione derivative and its use as antidiabetic

Publications (1)

Publication Number Publication Date
AU2001284274A1 true AU2001284274A1 (en) 2002-03-22

Family

ID=9899043

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001284274A Abandoned AU2001284274A1 (en) 2000-09-07 2001-09-05 A thiazolidinedione derivative and its use as antidiabetic

Country Status (14)

Country Link
US (1) US20040014791A1 (en)
EP (1) EP1315721B1 (en)
JP (1) JP2004508367A (en)
KR (1) KR100769007B1 (en)
CN (2) CN100415741C (en)
AT (1) ATE343574T1 (en)
AU (1) AU2001284274A1 (en)
CY (1) CY1105903T1 (en)
DE (1) DE60124119T2 (en)
DK (1) DK1315721T3 (en)
ES (1) ES2272528T3 (en)
GB (1) GB0021978D0 (en)
PT (1) PT1315721E (en)
WO (1) WO2002020517A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
DE102005034406A1 (en) * 2005-07-22 2007-02-01 Ratiopharm Gmbh New salts of rosiglitazone
US7435741B2 (en) 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
DE102009053562A1 (en) 2009-11-18 2011-05-19 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Pharmaceutical composition, useful for treating diabetes mellitus type 2 in a combination therapy with other antidiabetic agent, comprises rosiglitazone succinate as an active agent
US20130158077A1 (en) 2011-12-19 2013-06-20 Ares Trading S.A. Pharmaceutical compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE186724T1 (en) 1987-09-04 1999-12-15 Beecham Group Plc SUBSTITUTED THIAZOLIDINEDIONE DERIVATIVES
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5741803A (en) * 1992-09-05 1998-04-21 Smithkline Beecham Plc Substituted thiazolidinedionle derivatives
GB9711683D0 (en) 1997-06-05 1997-08-06 Smithkline Beecham Plc Composition
GB9726566D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726563D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726568D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
EP1093370B1 (en) * 1998-06-30 2006-02-22 Takeda Pharmaceutical Company Limited Pharmaceutical composition for the treatment of diabetes

Also Published As

Publication number Publication date
CN1814599A (en) 2006-08-09
KR100769007B1 (en) 2007-10-22
JP2004508367A (en) 2004-03-18
CN100415741C (en) 2008-09-03
ATE343574T1 (en) 2006-11-15
GB0021978D0 (en) 2000-10-25
ES2272528T3 (en) 2007-05-01
DK1315721T3 (en) 2007-02-19
KR20030031179A (en) 2003-04-18
PT1315721E (en) 2007-01-31
DE60124119T2 (en) 2007-05-16
EP1315721A1 (en) 2003-06-04
US20040014791A1 (en) 2004-01-22
CN1471530A (en) 2004-01-28
DE60124119D1 (en) 2006-12-07
CY1105903T1 (en) 2011-02-02
HK1057204A1 (en) 2004-03-19
WO2002020517A1 (en) 2002-03-14
EP1315721B1 (en) 2006-10-25

Similar Documents

Publication Publication Date Title
AU2001284274A1 (en) A thiazolidinedione derivative and its use as antidiabetic
NZ515166A (en) Thiazolidinedione derivative and its use as antidiabetic
AP1814A (en) Tartrate salts of thiazolidinedione derivative.
AU2001284285A1 (en) A thiazolidinedione derivative and its use as antidiabetic
AP1680A (en) Thiazolidinedione derivative and its use as antidiabetic.
AP1715A (en) The hydrochloride salt of 5-[ 4 -[2 -(n-methyl-n- (2-pyridyl) amino) ethoxy]benzyl]thiazolidine -2,4-dione
AU2002343052A1 (en) Rosiglitazone edisylates and their use as antidiabetics
PT1349855E (en) 5-`4-`2-(n-methyl-n- (2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione mesylate salt
AP2002002673A0 (en) Thiazolidinedione salt for the treatment of diabetes mellitus.
AP1785A (en) Tartrate salt of thiazolidinedione derivative.
AP2002002684A0 (en) 5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical
AP2003002737A0 (en) Tartrate salts of thiazolidinedione derivatives
AP1813A (en) Tartrate salts of thiazolidinedione derivative.
AP1841A (en) A thiazolidinedione derivative and its use as antidiabetic.
AU2002343050A1 (en) 5-(4-(2-(n-methyl-n-(2-pyridil) amino) ethoxy) benzyl) thiazolidine-2, 4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thereof; and its use as pharmaceutical active ingredient
EP1867343A3 (en) Inclusion complexes of a cyclodextrin with a thiazolidine-2,4-dione
HK1068883A (en) 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione and pharmaceutical compositions comprising the same
ECSP003434A (en) NEW COMPOUNDS